PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Cowpea is reported to have anti-diabetic, anti-cancer, anti-hyperlipidemic, anti-inflammatory, and anti-hypertensive properties, although results for anti-cancer and anti-inflammatory effects have been conflicting [PMID:29656381]
Methanolic extracts of cowpea pods demonstrated antibacterial activity against E. coli, S. pyogenes, and P. aeruginosa with a MIC of 100 μg/mL [PMID:36576750]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 33072144 (2020) — Introgression Breeding in Cowpea [Vigna unguiculata (L.) Walp.]. · Frontiers in plant science
- 2.PMID: 36987026 (2023) — Cowpea Constraints and Breeding in Europe. · Plants (Basel, Switzerland)
- 3.PMID: 25300846 (2015) — Cowpea [Vigna unguiculata (L.) Walp]. · Methods in molecular biology (Clifton, N.J.)
- 4.PMID: 31109137 (2019) — Genome Editing in Cowpea Vigna unguiculata Using CRISPR-Cas9. · International journal of molecular sciences
- 5.PMID: 34962416 (2022) — Aphelenchoides besseyi Parasitizing Cowpea (Vigna unguiculata) in Brazil. · Plant disease